POZ Community Forums
Meds, Mind, Body & Benefits => Questions About Treatment & Side Effects => Topic started by: newt on September 28, 2006, 03:02:06 pm
-
Lopinavir monotherapy: less potent than triple therapy with higher risk of resistance (http://www.i-base.info/htb/v7/htb7-9/Lopinavir.html)
Title of this report from 4 sessions, 3 of them late-breaker sessions, at the IAS conference, Toronto, says it all really.
- matt